Cirurgia do AVC Isquémico by Barbosa, MD
Marcos Barbosa   Serviço de Neurocirurgia                             1º Congresso Português do AVC
Hospitais da Universidade de Coimbra                                                     Porto, Fev 2007
CIRURGIA DO 
AVC ISQUÉMICO




CIRURGIA NO AVC AGUDO
A_andar.mpeg







CIRURGIA NO AVC AGUDO
AVC ISQUÉMICO
“não há evidência de estudos  
randomizados controlados…”
- HEADDFIRST, HAMLET, DECIMAL, HEMMI
- Porquê, quem e quando? 
HeaDDFIRST
Hemicraniectomy and Durotomy for Deterioration From Infarction Relating Swelling
TrialStatus:
completed
Enrollment began in February 2000 and will conclude January 31, 2002 with the goal of enrolling 75 total 
patients. Currently, 25 participating centers in North America ready to enroll patients. 
Interventions:
Hemicraniectomy





Multi-center pilot clinical trial with a planned enrollment of 75 patients.
Inclusion Criteria
Occurrence of an acute unilateral middle cerebral artery (MCA) territory ischemic stroke; must meet 
specific clinical and CT criteria. 
Patient Involvement:
All eligible and consenting patients will be registered and subjected to a standardized medical therapy (SMT) 
protocol. Patients who develop severe brain swelling within 96 hours of stroke onset will be randomized to 
receive SMT alone or SMT + standardized hemicraniectomy and durotomy. 
Primary Outcome:
Assessments of mortality, reportable events, functional outcome, quality of life, caregiving burden, patient 
perceptions of survivorship, and acute health care utilization measured 21, 90 and 180 days after stroke 
onset. 
HeMMI
Hemicraniectomy For Malignant Middle Cerebral Artery Infarcts 
Study Size Actual:15
Study Size Planned:56












Open randomized clinical trial. 
Inclusion Criteria
Patients diagnosed clinically and radiographically with ischemic stroke in the middle cerebral 
artery territory 
Exclusion Criteria
Patients with a previos disabling neurological disease or a modified Rankin score > 2, Glasgow Coma 
Scale score of < 5, terminal illness, infarction due to surgical complications or vasopasm, primary 
intracranial hemorrhage or coagulopathies 
Patient Involvement:
Patients medically cleared for possible surgery will be randomized to receive either standard medical 
treatment or hemicraniectomy with duraplasty. The GCS score and NIHSS score will be monitored daily for 
the first 7 days, at 2 weeks, at discharge, 1, 3, and 6 months. The modified Rankin score and Barthel 
Index will be assessed at discharge, 2 weeks, 1, 3, and 6 months. 
Primary Outcome:
GCS, NIHSS, modified Rankin score and Barthel Index. 
HAMLET
Hemicraniectomy After MCA infarction with Life-threatening Edema Trial
Status:
As of November 2005, 44 patients had been enrolled at 7 centers. Trial is ongoing with a planned enrollment of 
112. 
Purpose:
To study the efficacy of decompressive surgery to reduce mortality and to improve functional outcome in patients 
with supratentorial infarction and space-occupying edema. 
Interventions:
Hemicraniectomy
Surgical procedure to reduce intracranial pressure after large hemispheric infaction.
Year Started: 2002
Design:
Multi-center, open, randomized clinical trial of 112 patients.
Inclusion Criteria
Space-occupying infarct in the territory of the middle cerebral artery in either hemisphere leading to a 
decrease in consciousness
Patient Involvement:
Patients will be randomized to either decompressive surgery, consisting of a large hemicraniectomy and a 
duraplasty, followed by intensive care treatment, or conservative treatment, consisting of either intensive care 
treatment or 'standard' therapy on a stroke unit. Randomization will be stratified according to the intended mode of 
conservative treatment. 
Primary Outcome:
The primary outcome measure is functional outcome according to the modified Rankin Scale at one year. 
Secondary Outcome:
Other outcome measures include the Barthel Index, the NIH Stroke Scale, the Montgomery and Asberg 
Depression Rating Scale, and quality of life as determined by the SF36 as well as a visual analogue scale. 
DECIMAL
DEcompressive Craniectomy In MALignant Middle Cerebral Artery Infarcts Status:
As of December of 2004, 32 patients had been enrolled at 13 French centers. Recruitment is ongoing. 
Purpose:
To assess the efficacy of decompressive hemicraniectomy and duroplasty in patients with malignant middle 





Sequential design, multi-center, randomized, controlled trial. 
Inclusion Criteria
Patients who present within 24 hours of a malignant MCA infarct - a severe ischemic hemispheric 
stroke (NIHSS > 15, altered level of consciousness and brain CT ischemic early signs > 50% of the 
MCA territory) and a DWI infarct volume > 145 cm3.
Patient Involvement:
Patients will be randomly assigned to either receive standard treatment alone or in combination with 
decompressive hemicraniectomy and duroplasty. 
Primary Outcome:
Modified Rankin Score < 4 at 6 months. 
Secondary Outcome:
NIHSS, modified Rankin Scale, Barthel Index and quality of life measured by Stroke Impact Scale at 6 
months and 1 year
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 SUPRATENTORIAL
- mortalidade do edema maligno 80%
- tratamento conservador pouco eficaz
- aumento da sobrevivência
- bons resultados funcionais
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 SUPRATENTORIAL
- critérios preditivos de agravamento
clínicos
imagiológicos
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 SUPRATENTORIAL
- critérios clínicos de diagnóstico:
estado consciência, hemiplegia (afasia), anisocória,  
desvio óculo-cefálico….







 Desvio linha média
 Hiperdensidade ACM
 Compressão espaço subaracnoideu




















CIRURGIA NO AVC AGUDO
CIRURGIA NO AVC AGUDO




CIRURGIA NO AVC AGUDO
AVC ISQUÉMICO
 SUPRATENTORIAL
- selecção para cirurgia
idade
envolvimento de outros territórios
hemisfério dominante
EG, sexo, anisocória
CIRURGIA NO AVC AGUDO
AVC ISQUÉMICO
 SUPRATENTORIAL
- quando operar ?
80% → 16% → 34,4 %
melhoria dos resultados funcionais
(Schwab S et al, Stroke 29:1888-93, 1998)





abertura da dura 
duroplastia
cranioplastia 



















idade ≤50 anos versus >50 anos  (p =0.02)
ACM versus ACM + adicional (p =0.01)
(Uhl E et al, J Neurol Neurosurg Psychiatry 75:270-4, 2004)




I. Barthel >70 = 24.2%; ≤70 = 75,8%
GOS 1-2 =19,7%; GOS 3 = 47,9%; GOS 4 = 1,6%
≤50 anos GOS 1-2 = 34,9%
>50 anos GOS 1-2 = 12%      (p <0.0003)
(Uhl E et al, J Neurol Neurosurg Psychiatry 75:270-4, 2004)




cirurgia precoce com melhores resultados
funcionais que cirurgia tardia  (p <0.05)
(Mori K et al Surg Neurol 62:420-9, 2004)
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Neurological recovery after decompressive craniectomy for
massive ischemic stroke
Cheung A , et al
Neurocrit Care. 2005;3(3):216-23
“the evidence of functional recovery in peri-infarct regions
suggests that decompression alone may be preferable to
strokectomy where the risk of damage to adjacent
nonischemic brain may be greater”.
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Factors affecting the outcome of decompressive 
craniectomy for large hemispheric infarctions
Kilincer C, et al 
Acta Neurochir (Wien). 2005 Jun;147(6):587-94
“…life-sparing procedure that sometimes yields good 
functional outcomes. A dominant hemispheric infarction 
should not be an exclusion criterion when deciding to 
perform this operation. Early operation and careful patient 
selection based on the above-mentioned factors may 
improve the functional outcome of surgical management 
for large hemispheric infarction”. 
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Is decompressive craniectomy for malignant middle
Cerebral artery territory infarction of any benefit for elderly
patients?
Yao Y , et al
Surg Neurol. 2005 Aug;64(2):165-9
“decompressive craniectomy in younger patients with
malignant MCA territory infarction improves both survival
rates and functional outcomes. Although survival rates
were improved after surgery in elderly patients, functional
outcome and level of independence were poor”.
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Outcome after decompressive craniectomy in patients 
with severe ischemic stroke.
Harscher S, et al
Acta Neurochir (Wien). 2006 Jan;148(1):31-7
“our small observational, retrospective study suggests that 
hemicraniectomy in patients with space occupying MCA-
infarction decreases mortality rate and increases 
functional outcome”. 
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Decompressive craniectomy for ischemic stroke
Matsuura D, et al 
No To Shinkei. 2006 Apr;58(4):305-10
“…comprehensive evaluations, including satisfaction scale
and QOL assessment necessary to decide the indication of
decompressive craniectomy for ischemic stroke. 
Although many patients were severely disabled, 79% of the
patients and their family answered that having operation
was correct choice”
CIRURGIA NO AVC AGUDO
CONCLUSÃO
craniectomia descompressiva salva vidas e 
proporciona boa qualidade de vida numa grande 
proporção de casos, especialmente nos doentes 
mais novos
necessidade de se estabelecerem protocolos 
(unidades de AVC)
